PubMed (OMIM) for id: 343428

Year	Number of Results
1985	2
1987	1
1993	2
1994	2
1995	1
1996	3
1997	1
1998	2
1999	1
2000	1
2001	1
2002	4
2003	1
2005	1
2024	0

1

ROMK1 channel activity is regulated by monoubiquitination.

Lin DH, Sterling H, Wang Z, Babilonia E, Yang B, Dong K, Hebert SC, Giebisch G, Wang WH. Lin DH, et al. Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4306-11. doi: 10.1073/pnas.0409767102. Epub 2005 Mar 14. Proc Natl Acad Sci U S A. 2005. PMID: 15767585 Free PMC article.

2

Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome.

Finer G, Shalev H, Birk OS, Galron D, Jeck N, Sinai-Treiman L, Landau D. Finer G, et al. J Pediatr. 2003 Mar;142(3):318-23. doi: 10.1067/mpd.2003.100. J Pediatr. 2003. PMID: 12640382

3

Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.

Lu M, Wang T, Yan Q, Yang X, Dong K, Knepper MA, Wang W, Giebisch G, Shull GE, Hebert SC. Lu M, et al. J Biol Chem. 2002 Oct 4;277(40):37881-7. doi: 10.1074/jbc.M206644200. Epub 2002 Jul 18. J Biol Chem. 2002. PMID: 12130653 Free PMC article.

4

Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome.

Lorenz JN, Baird NR, Judd LM, Noonan WT, Andringa A, Doetschman T, Manning PA, Liu LH, Miller ML, Shull GE. Lorenz JN, et al. J Biol Chem. 2002 Oct 4;277(40):37871-80. doi: 10.1074/jbc.M205627200. Epub 2002 Jul 16. J Biol Chem. 2002. PMID: 12122007 Free article.

5

Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies.

Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE. Lopes CM, et al. Neuron. 2002 Jun 13;34(6):933-44. doi: 10.1016/s0896-6273(02)00725-0. Neuron. 2002. PMID: 12086641 Free article.

6

Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus G Gü, Konrad M, Seyberth HW. Peters M, et al. Am J Med. 2002 Feb 15;112(3):183-90. doi: 10.1016/s0002-9343(01)01086-5. Am J Med. 2002. PMID: 11893344

7

Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome.

Jeck N, Derst C, Wischmeyer E, Ott H, Weber S, Rudin C, Seyberth HW, Daut J, Karschin A, Konrad M. Jeck N, et al. Kidney Int. 2001 May;59(5):1803-11. doi: 10.1046/j.1523-1755.2001.0590051803.x. Kidney Int. 2001. PMID: 11318951 Free article.

8

New treatment options for Bartter's syndrome.

Kleta R, Basoglu C, Kuwertz-Bröking E. Kleta R, et al. N Engl J Med. 2000 Aug 31;343(9):661-2. doi: 10.1056/NEJM200008313430915. N Engl J Med. 2000. PMID: 10979805 No abstract available.

9

Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes.

Konrad M, Leonhardt A, Hensen P, Seyberth HW, Köckerling A. Konrad M, et al. Pediatrics. 1999 Mar;103(3):678-83. doi: 10.1542/peds.103.3.678. Pediatrics. 1999. PMID: 10049979

10

A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels.

Derst C, Wischmeyer E, Preisig-Müller R, Spauschus A, Konrad M, Hensen P, Jeck N, Seyberth HW, Daut J, Karschin A. Derst C, et al. J Biol Chem. 1998 Sep 11;273(37):23884-91. doi: 10.1074/jbc.273.37.23884. J Biol Chem. 1998. PMID: 9727001 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year